Cargando…

Changes in renal function and occurrence of contrast-induced nephropathy after percutaneous coronary interventions in patients with atrial fibrillation treated with non-vitamin K oral anticoagulants or warfarin

INTRODUCTION: Patients with atrial fibrillation (AF) receiving non-vitamin K oral anticoagulants (NOAC) have a slower decline in renal function than those taking warfarin. Moreover, a warfarin-related nephropathy has been described. AIM: We assessed variation of estimated glomerular filtration rate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montone, Rocco A., Niccoli, Giampaolo, Tufaro, Vincenzo, Minelli, Silvia, Russo, Michele, Vergni, Federico, Sommariva, Luigi, Pelliccia, Francesco, Bedogni, Francesco, Crea, Filippo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488841/ https://www.ncbi.nlm.nih.gov/pubmed/31043986 http://dx.doi.org/10.5114/aic.2019.83772

Ejemplares similares

Unprotected left main revascularization: Percutaneous coronary intervention versus coronary artery bypass. An updated systematic review and meta-analysis of randomised controlled trials
por: Testa, Luca, et al.
Publicado: (2017)

Mid-Term Outcome of Ventricular Arrhythmias Catheter Ablation in Patients with Chronic Coronary Total Occlusion Compared to Ischemic and Non-Ischemic Patients
por: Narducci, Maria Lucia, et al.
Publicado: (2022)

MINOCA: current perspectives
por: Montone, Rocco A., et al.
Publicado: (2018)

Randomised trials and meta-analyses of double vs triple antithrombotic therapy for atrial fibrillation-ACS/PCI: A critical appraisal
por: Galli, Mattia, et al.
Publicado: (2020)

In-stent restenosis after percutaneous coronary intervention: emerging knowledge on biological pathways
por: Pelliccia, Francesco, et al.
Publicado: (2023)

Myocardial and Microvascular Injury Due to Coronavirus Disease 2019
por: Montone, Rocco A, et al.
Publicado: (2020)

Bioresorbable vascular scaffolds: between promises and reality
por: Montone, Rocco A., et al.
Publicado: (2017)

The management of non-culprit coronary lesions in patients with acute coronary syndrome
por: Montone, Rocco A, et al.
Publicado: (2020)

Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
por: D’Amario, Domenico, et al.
Publicado: (2019)

The Occurrence of Warfarin-Related Nephropathy and Effects on Renal and Patient Outcomes in Korean Patients
por: An, Jung Nam, et al.
Publicado: (2013)

Warfarin-related Nephropathy
por: Golla, Anvesh, et al.
Publicado: (2018)

Sustained safe and effective anticoagulation using Edoxaban via percutaneous endoscopic gastrostomy
por: Galli, Mattia, et al.
Publicado: (2019)

Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile
por: Di Maso, Vittorio, et al.
Publicado: (2014)

Long-Term Outcomes of Extent of Revascularization in Complex High Risk and Indicated Patients Undergoing Impella-Protected Percutaneous Coronary Intervention: Report from the Roma-Verona Registry
por: Burzotta, Francesco, et al.
Publicado: (2019)

Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome
por: Giarretta, Igor, et al.
Publicado: (2022)

Impact of the exposome on cardiovascular disease
por: Bonanni, Alice, et al.
Publicado: (2023)

Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective
por: Gragnano, Felice, et al.
Publicado: (2023)

Interplay Between Myocardial Bridging and Coronary Spasm in Patients With Myocardial Ischemia and Non‐Obstructive Coronary Arteries: Pathogenic and Prognostic Implications
por: Montone, Rocco A., et al.
Publicado: (2021)

Measurement of Warfarin in the Oral Fluid of Patients Undergoing Anticoagulant Oral Therapy
por: Ghimenti, Silvia, et al.
Publicado: (2011)

Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2021)

Prothrombin complex concentrates in warfarin anticoagulation reversal
por: Costa-Lima, Carolina, et al.
Publicado: (2012)

Graves' Disease and Treatment Effects on Warfarin Anticoagulation
por: Howard-Thompson, Amanda, et al.
Publicado: (2014)

Beyond warfarin: The advent of new oral anticoagulants
por: Laroia, Sandeep T, et al.
Publicado: (2015)

Beyond warfarin: The advent of new oral anticoagulants
por: Malhotra, Konark, et al.
Publicado: (2016)

Piperine Alters the Pharmacokinetics and Anticoagulation of Warfarin in Rats
por: Zayed, Aref, et al.
Publicado: (2020)

Quality of anticoagulation with warfarin in rural Chhattisgarh, India
por: Chebrolu, Puja, et al.
Publicado: (2020)

The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study
por: Gemmati, Donato, et al.
Publicado: (2016)

Microvascular complications identify a specific coronary atherosclerotic phenotype in patients with type 2 diabetes mellitus
por: Montone, Rocco A., et al.
Publicado: (2022)

Evaluation of an electronic warfarin nomogram for anticoagulation of hemodialysis patients
por: Thomson, Benjamin KA, et al.
Publicado: (2011)

Management of Warfarin Anticoagulation in Patients with Fractured Neck of Femur
por: Ashouri, Feras, et al.
Publicado: (2011)

Quality of Anticoagulation With Warfarin at a Tertiary Hospital in Botswana
por: Mwita, Julius C., et al.
Publicado: (2017)

Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
por: Stolz, Leonie, et al.
Publicado: (2017)

Effect of rifampicin on anticoagulation of warfarin: A case report
por: Hu, Ya-Ni, et al.
Publicado: (2021)

Dual Anticoagulation With Warfarin and Apixaban: A Case Report
por: Parker, Kristen, et al.
Publicado: (2022)

Developing LRP1 Agonists into a Therapeutic Strategy in Acute Myocardial Infarction
por: Potere, Nicola, et al.
Publicado: (2019)

Data on optical coherence tomography guidance for the management of angiographically intermediate left main bifurcation lesions
por: Dato, Ilaria, et al.
Publicado: (2017)

Dual Antiplatelet Therapy or Antiplatelet Plus Anticoagulant Therapy in Patients with Peripheral and Chronic Coronary Artery Disease: An Updated Review
por: Magnani, Giulia, et al.
Publicado: (2023)

Uric acid and contrast-induced nephropathy: an updated review and meta-regression analysis
por: Pelliccia, Francesco, et al.
Publicado: (2018)

Association of Direct Oral Anticoagulants (DOACs) and Warfarin With Haemorrhagic Risk by Applying Correspondence Analysis to Data From the Italian Pharmacovigilance Database – A Case Study
por: Gaio, Mario, et al.
Publicado: (2021)

Warfarin-related nephropathy in a patient with mild IgA nephropathy on dabigatran and aspirin
por: Moeckel, Gilbert W., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_m9c1fumoko259pgnn2bhbubhpp